Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997–2020)

Chimeric antigen receptor and T-cell receptor (CAR-T/TCR-T) cellular immunotherapies have shown remarkable success in the treatment of some refractory B-cell malignancies, with potential to provide durable clinical response for other types of cancer. In this paper, we look at all available FDA CAR-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivica, Nikola A., Young, Colin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392279/
https://www.ncbi.nlm.nih.gov/pubmed/34442199
http://dx.doi.org/10.3390/healthcare9081062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392279/
https://www.ncbi.nlm.nih.gov/pubmed/34442199
http://dx.doi.org/10.3390/healthcare9081062

Ejemplares similares